Gainers

• NovaBay Pharmaceuticals (AMEX:NBY) shares moved upwards by 6.8% to $1.56 during Wednesday's after-market session. The company's market cap stands at $38.6 million.
• SCWorx (NASDAQ:WORX) shares increased by 5.88% to $0.14. The market value of their outstanding shares is at $2.8 million.
• Veeva Systems (NYSE:VEEV) stock increased by 5.23% to $198.23. The market value of their outstanding shares is at $30.5 billion. The company's, Q4 earnings came out today.
• Quince Therapeutics (NASDAQ:QNCX) shares moved upwards by 3.75% to $0.11. The company's market cap stands at $5.3 million.
• Ernexa Therapeutics (NASDAQ:ERNA) shares moved upwards by 3.55% to $0.32. The market value of their outstanding shares is at $8.0 million.
• aTyr Pharma (NASDAQ:ATYR) stock rose 2.43% to $0.99. The company's market cap stands at $94.0 million.

Losers

• Modular Medical (NASDAQ:MODD) shares decreased by 6.3% to $0.18 during Wednesday's after-market session. The company's market cap stands at $13.0 million.
• Iterum Therapeutics (NASDAQ:ITRM) stock decreased by 5.05% to $0.16. The company's market cap stands at $7.9 million.
• Cypherpunk Technologies (NASDAQ:CYPH) shares fell 4.19% to $0.69. The company's market cap stands at $34.8 million.
• Firefly Neuroscience (NASDAQ:AIFF) stock decreased by 3.88% to $1.49. The company's market cap stands at $9.7 million.
• Can Fite Biopharma (AMEX:CANF) stock decreased by 3.83% to $5.78. The company's market cap stands at $6.5 million.
• iSpecimen (NASDAQ:ISPC) stock declined by 3.65% to $0.25. The company's market cap stands at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.